表紙
市場調查報告書

全球院內傳染病檢查市場:世界產業趨勢,佔有率,規模,成長,機會,預測

Hospital Acquired Disease Testing Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2018-2023

出版商 IMARC Services Private Limited 商品編碼 757534
出版日期 內容資訊 英文 74 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
全球院內傳染病檢查市場:世界產業趨勢,佔有率,規模,成長,機會,預測 Hospital Acquired Disease Testing Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2018-2023
出版日期: 2018年12月14日內容資訊: 英文 74 Pages
簡介

本報告提供全球院內傳染病檢查市場相關調查,彙整市場趨勢與各市場區隔趨勢,各地區預測,加入此市場的主要企業的簡介相關資訊。

第1章 序論

第2章 調查範圍和調查方法

第3章 摘要整理

第4章 簡介

  • 概要
  • 產業趨勢

第5章 全球院內傳染病檢查市場

  • 市場概要
  • 市場成果
  • 各適應症市場
  • 各地區市場
  • 市場預測
  • SWOT分析
  • 價值鏈分析
  • 波特五力分析
  • 價格分析

第6章 各適應症市場

  • UTI(尿道感染)
  • SSI(手術部位感染)
  • 肺炎
  • MRSA(抗藥性金黃色葡萄球菌感染疾病)
  • 其他

第7章 各地區市場

  • 北美
  • 歐洲
  • 亞太地區
  • 中東、非洲
  • 南美

第8章 競爭環境

  • 市場結構
  • 主要加入企業
  • 主要加入企業的簡介
    • Abbott Laboratories
    • Alere, Inc.
    • Becton, Dickinson and Company
    • bioMerieux SA
    • F. Hoffmann-La Roche Ltd.
    • Hologic, Inc.
    • QIAGEN
    • Siemens Healthcare
    • Diatherix Laboratories, Inc.
    • Meridian Bioscience, Inc.
    • Thermo Fisher Scientific, Inc. (Life Technologies Corporation)
    • Cepheid, Inc.
目錄
Product Code: SR1018G5_Report

The global hospital acquired disease testing market was worth US$ 752 Million in 2017. Hospital acquired infections (HAIs) or nosocomial infections are diseases that are acquired in hospitals and medical clinics. Nosocomial means, infections or diseases originating in a hospital. A person can get such diseases even in the vicinity of a nursing home, rehabilitation center, hospital or any other clinical surroundings. Most people get HAIs when they are in intensive care units (ICUs) and the emergency rooms (ERs). Generally, the incubation period of these diseases vary between 48 hours to 4 days after the individual gets admitted. A major reason behind the cause of hospital acquired diseases is the lack of proper hygiene in the hospital settings by the internal staff. Another reason can be below-par maintenance, complacency by the hospital staff, and a rise in multi-drug resistant organisms (MDROs). Some of the most commonly occurring nosocomial infections include pneumonia, primary bloodstream infections, urinary tract infections, etc. In many cases, it has also been found that these nosocomial infections are sometimes traced to the patients' own microbiome. It happens when the protective skin layer comes in contact with possible threats and causes infection to occur, especially after surgical operations.

The market for hospital acquired disease testing is currently exhibiting double digit growth rates. Catalyzed by rising population and modernization of the healthcare infrastructure, there has been a significant increase in the number of health care facilities across the globe. This has resulted in a rising incidence of HAIs, driving the demand of hospital acquired disease tests. Moreover, with advanced technologies and scientific innovations, various techniques are now available in the market for preventing, diagnosing, and monitoring HAIs such as microarrays, polymerase chain reaction (PCR), real time location systems (RTLSs), and solid phase hybridization. Techniques such as RTLS makes it easy to prevent HAIs from spreading in both patients and staff. Growing awareness of HAIs among patients and governments enacting regulations that penalize hospitals having a high incidence of HAIs are some of the other factors that are catalyzing the growth of the market. Looking forward, the market value is projected to exceed US$ 1,720 Million by 2023, exhibiting a CAGR of around 18% during 2018-2023.

Market Summary:

  • Based on the indication, the market has been segmented into urinary tract infection, surgical site infection, pneumonia, bloodstream infections, methicillin-resistant staphylococcus aureus and others. Urinary tract infection currently represents the biggest segment.
  • Region-wise, the market has been segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.
  • The competitive landscape of the market has also been examined with some of the key players being Abbott Laboratories, Alere, Inc., Becton, Dickinson and Company, bioMerieux SA, F. Hoffmann-La Roche Ltd., Hologic, Inc., QIAGEN, Siemens Healthcare, Diatherix Laboratories, Inc., Meridian Bioscience, Inc., Thermo Fisher Scientific, Inc. (Life Technologies Corporation) and Cepheid, Inc.
  • This report provides a deep insight into the global hospital acquired disease testing market covering all its essential aspects. This ranges from macro overview of the market to micro details of the industry performance, recent trends, key market drivers and challenges, SWOT analysis, Porter's five forces analysis, value chain analysis, etc. This report is a must-read for entrepreneurs, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the hospital acquired disease testing market in any manner.

Key Questions Answered in This Report:

  • How has the global hospital acquired disease testing market performed so far and how will it perform in the coming years?
  • What are the key regional markets in the global hospital acquired disease testing industry?
  • What is the breakup of the global hospital acquired disease market on the basis of indication?
  • What are the various stages in the value chain of the global hospital acquired disease testing market?
  • What are the key driving factors and challenges in the global hospital acquired disease testing market?
  • What is the structure of the global hospital acquired disease testing market and who are the key players?
  • What is the degree of competition in the global hospital acquired disease testing market?

Table of Contents

1. Preface

2. Scope and Methodology

  • 2.1. Objectives of the Study
  • 2.2. Stakeholders
  • 2.3. Data Sources
    • 2.3.1. Primary Sources
    • 2.3.2. Secondary Sources
  • 2.4. Market Estimation
    • 2.4.1. Bottom-Up Approach
    • 2.4.2. Top-Down Approach
  • 2.5. Forecasting Methodology

3. Executive Summary

4. Introduction

  • 4.1. Overview
  • 4.2. Key Industry Trends

5. Global Hospital Acquired Disease Testing Market

  • 5.1. Market Overview
  • 5.2. Market Performance
  • 5.3. Market Breakup by Indication
  • 5.4. Market Breakup by Region
  • 5.5. Market Forecast
  • 5.6. SWOT Analysis
    • 5.6.1. Overview
    • 5.6.2. Strengths
    • 5.6.3. Weaknesses
    • 5.6.4. Opportunities
    • 5.6.5. Threats
  • 5.7. Value Chain Analysis
  • 5.8. Porters Five Forces Analysis
    • 5.8.1. Overview
    • 5.8.2. Bargaining Power of Buyers
    • 5.8.3. Bargaining Power of Suppliers
    • 5.8.4. Degree of Competition
    • 5.8.5. Threat of New Entrants
    • 5.8.6. Threat of Substitutes
  • 5.9. Price Analysis

6. Market Breakup by Indication

  • 6.1. UTI (Urinary Tract Infection)
    • 6.1.1. Market Trends
    • 6.1.2. Market Forecast
  • 6.2. SSI (Surgical Site Infection)
    • 6.2.1. Market Trends
    • 6.2.2. Market Forecast
  • 6.3. Pneumonia
    • 6.3.1. Market Trends
    • 6.3.2. Market Forecast
  • 6.4. Bloodstream Infections
    • 6.4.1. Market Trends
    • 6.4.2. Market Forecast
  • 6.5. MRSA (Methicillin-Resistant Staphylococcus Aureus)
    • 6.5.1. Market Trends
    • 6.5.2. Market Forecast
  • 6.6. Others
    • 6.6.1. Market Trends
    • 6.6.2. Market Forecast

7. Market Breakup by Region

  • 7.1. North America
    • 7.1.1. Market Trends
    • 7.1.2. Market Forecast
  • 7.2. Europe
    • 7.2.1. Market Trends
    • 7.2.2. Market Forecast
  • 7.3. Asia Pacific
    • 7.3.1. Market Trends
    • 7.3.2. Market Forecast
  • 7.4. Middle East and Africa
    • 7.4.1. Market Trends
    • 7.4.2. Market Forecast
  • 7.5. Latin America
    • 7.5.1. Market Trends
    • 7.5.2. Market Forecast

8. Competitive Landscape

  • 8.1. Market Structure
  • 8.2. Key Players
  • 8.3. Profiles of Key Players
    • 8.3.1. Abbott Laboratories
    • 8.3.2. Alere, Inc.
    • 8.3.3. Becton, Dickinson and Company
    • 8.3.4. bioMerieux SA
    • 8.3.5. F. Hoffmann-La Roche Ltd.
    • 8.3.6. Hologic, Inc.
    • 8.3.7. QIAGEN
    • 8.3.8. Siemens Healthcare
    • 8.3.9. Diatherix Laboratories, Inc.
    • 8.3.10. Meridian Bioscience, Inc.
    • 8.3.11. Thermo Fisher Scientific, Inc. (Life Technologies Corporation)
    • 8.3.12. Cepheid, Inc.

List of Figures

  • Figure 1: Global: Hospital Acquired Disease Testing Market: Major Drivers and Challenges
  • Figure 2: Global: Hospital Acquired Disease Testing Market: Sales Value (in Million US$), 2010-2017
  • Figure 3: Global: Hospital Acquired Disease Testing Market: Breakup by Indication (in %), 2017
  • Figure 4: Global: Hospital Acquired Disease Testing Market: Breakup by Region (in %), 2017
  • Figure 5: Global: Hospital Acquired Disease Testing Market Forecast: Sales Value (in Million US$), 2018-2023
  • Figure 6: Global: Hospital Acquired Disease Testing Industry: SWOT Analysis
  • Figure 7: Global: Hospital Acquired Disease Testing Industry: Porter's Five Forces Analysis
  • Figure 8: Global: Hospital Acquired Disease Testing (Urinary Tract Infection) Market: Sales Value (in Million US$), 2010 & 2017
  • Figure 9: Global: Hospital Acquired Disease Testing (Urinary Tract Infection) Market Forecast: Sales Value (in Million US$), 2018-2023
  • Figure 10: Global: Hospital Acquired Disease Testing (Surgical Site Infection) Market: Sales Value (in Million US$), 2010 & 2017
  • Figure 11: Global: Hospital Acquired Disease Testing (Surgical Site Infection) Market Forecast: Sales Value (in Million US$), 2018-2023
  • Figure 12: Global: Hospital Acquired Disease Testing (Pneumonia) Market: Sales Value (in Million US$), 2010 & 2017
  • Figure 13: Global: Hospital Acquired Disease Testing (Pneumonia) Market Forecast: Sales Value (in Million US$), 2018-2023
  • Figure 14: Global: Hospital Acquired Disease Testing (Bloodstream Infections) Market: Sales Value (in Million US$), 2010 & 2017
  • Figure 15: Global: Hospital Acquired Disease Testing (Bloodstream Infections) Market Forecast: Sales Value (in Million US$), 2018-2023
  • Figure 16: Global: Hospital Acquired Disease Testing (Methicillin-Resistant Staphylococcus Aureus) Market: Sales Value (in Million US$), 2010 & 2017
  • Figure 17: Global: Hospital Acquired Disease Testing (Methicillin-Resistant Staphylococcus Aureus) Market Forecast: Sales Value (in Million US$), 2018-2023
  • Figure 18: Global: Hospital Acquired Disease Testing (Other Product Types) Market: Sales Value (in Million US$), 2010 & 2017
  • Figure 19: Global: Hospital Acquired Disease Testing (Other Product Types) Market Forecast: Sales Value (in Million US$), 2018-2023
  • Figure 20: North America: Hospital Acquired Disease Testing Market: Sales Value (in Million US$), 2010 & 2017
  • Figure 21: North America: Hospital Acquired Disease Testing Market Forecast: Sales Value (in Million US$), 2018-2023
  • Figure 22: Europe: Hospital Acquired Disease Testing Market: Sales Value (in Million US$), 2010 & 2017
  • Figure 23: Europe: Hospital Acquired Disease Testing Market Forecast: Sales Value (in Million US$), 2018-2023
  • Figure 24: Asia Pacific: Hospital Acquired Disease Testing Market: Sales Value (in Million US$), 2010 & 2017
  • Figure 25: Asia Pacific: Hospital Acquired Disease Testing Market Forecast: Sales Value (in Million US$), 2018-2023
  • Figure 26: Middle East and Africa: Hospital Acquired Disease Testing Market: Sales Value (in Million US$), 2010 & 2017
  • Figure 27: Middle East and Africa: Hospital Acquired Disease Testing Market Forecast: Sales Value (in Million US$), 2018-2023
  • Figure 28: Latin America: Hospital Acquired Disease Testing Market: Sales Value (in Million US$), 2010 & 2017
  • Figure 29: Latin America: Hospital Acquired Disease Testing Market Forecast: Sales Value (in Million US$), 2018-2023

List of Tables

  • Table 1: Global: Hospital Acquired Disease Testing Market: Key Industry Highlights, 2017 and 2023
  • Table 2: Global: Hospital Acquired Disease Testing Market Forecast: Breakup by Indication (in Million US$), 2018-2023
  • Table 3: Global: Hospital Acquired Disease Testing Market Forecast: Breakup by Region (in Million US$), 2018-2023
  • Table 4: Global: Hospital Acquired Disease Testing Market Structure
  • Table 5: Global: Hospital Acquired Disease Testing Market: Key Players
Back to Top